Latest Breaking News On - உட்செலுத்துதல் அமைப்புகள் - Page 1 : comparemela.com
Global Intravenous Equipment Market Report 2021-2027: Smart Infusion Systems - Marking the Convergence of Healthcare IT & IV Drug Delivery Systems
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Intravenous Equipment Market Report 2021-2027: Smart Infusion Systems - Marking the Convergence of Healthcare IT & IV Drug Delivery Systems
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Smiths Group (LSE:SMIN) | RNS | Smiths Group PLC - Proposed Sale of Smiths Medical
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.
Operator
Good day, and welcome to the ICU Medical, Inc.s Q1 2021 Earnings Call. Today s conference is being recorded. At this time, I will turn the conference over to Mr. John Mills. Please go ahead, sir.
John Mills
Analyst
Great. Thank you. Good afternoon, everyone. Thank you for joining us today to discuss ICU Medical financial results for the first quarter of 2021. On the call today representing ICU Medical is Vivek Jain, CEO and Chairman; and Brian Bonnell, Chief Financial Officer. We want to let everyone know that we have a presentation accompanying today s prepared remarks. To view the presentation, please go to the investor page and click on events calendar, and it will be under the first quarter 2021 events. Before we start our prepared remarks, I want to touch upon any forward-looking statements made during the call, including beliefs and expectations about the company s future results. Please be aware they are based on the best available information to management and
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
Standalone Diabetes Care business expected to leverage position as global leader in insulin delivery and expand presence in large and high-growth diabetes market
- Spinoff allows both BD and NewCo to enhance each company s focus on meeting the needs of their respective patients, customers and stakeholders.
- BD management expects the transaction to strengthen its mid-single-digit revenue growth and double-digit total return growth profile.
- Transaction expected to be completed in first half of calendar year 2022.
- Management will provide further details during the company s announced fiscal second quarter results call today at 8 a.m. Eastern Time.